nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulindac—PTGS2—Barrett's esophagus	0.432	1	CbGaD
Sulindac—CYP1A1—Omeprazole—Barrett's esophagus	0.182	0.691	CbGbCtD
Sulindac—CYP1A2—Omeprazole—Barrett's esophagus	0.0815	0.309	CbGbCtD
Sulindac—MAPK3—exocrine gland—Barrett's esophagus	0.00896	0.194	CbGeAlD
Sulindac—AKR1B1—epithelium—Barrett's esophagus	0.00538	0.117	CbGeAlD
Sulindac—AKR1B1—smooth muscle tissue—Barrett's esophagus	0.00518	0.112	CbGeAlD
Sulindac—Allergic cutaneous angiitis—Esomeprazole—Barrett's esophagus	0.00494	0.0292	CcSEcCtD
Sulindac—Allergic cutaneous angiitis—Omeprazole—Barrett's esophagus	0.00494	0.0292	CcSEcCtD
Sulindac—AKR1B1—digestive system—Barrett's esophagus	0.00409	0.0887	CbGeAlD
Sulindac—MAPK3—epithelium—Barrett's esophagus	0.0039	0.0845	CbGeAlD
Sulindac—MAPK3—smooth muscle tissue—Barrett's esophagus	0.00376	0.0814	CbGeAlD
Sulindac—Nephrotic syndrome—Esomeprazole—Barrett's esophagus	0.00325	0.0192	CcSEcCtD
Sulindac—Nephrotic syndrome—Omeprazole—Barrett's esophagus	0.00325	0.0192	CcSEcCtD
Sulindac—PPARD—digestive system—Barrett's esophagus	0.00322	0.0697	CbGeAlD
Sulindac—Leukocytoclastic vasculitis—Omeprazole—Barrett's esophagus	0.0032	0.0189	CcSEcCtD
Sulindac—Leukocytoclastic vasculitis—Esomeprazole—Barrett's esophagus	0.0032	0.0189	CcSEcCtD
Sulindac—MAPK3—digestive system—Barrett's esophagus	0.00297	0.0643	CbGeAlD
Sulindac—Nephritis interstitial—Esomeprazole—Barrett's esophagus	0.00233	0.0137	CcSEcCtD
Sulindac—Nephritis interstitial—Omeprazole—Barrett's esophagus	0.00233	0.0137	CcSEcCtD
Sulindac—Tubulointerstitial nephritis—Esomeprazole—Barrett's esophagus	0.00205	0.0121	CcSEcCtD
Sulindac—Tubulointerstitial nephritis—Omeprazole—Barrett's esophagus	0.00205	0.0121	CcSEcCtD
Sulindac—Ageusia—Omeprazole—Barrett's esophagus	0.00194	0.0115	CcSEcCtD
Sulindac—Ageusia—Esomeprazole—Barrett's esophagus	0.00194	0.0115	CcSEcCtD
Sulindac—Proteinuria—Esomeprazole—Barrett's esophagus	0.00179	0.0106	CcSEcCtD
Sulindac—Proteinuria—Omeprazole—Barrett's esophagus	0.00179	0.0106	CcSEcCtD
Sulindac—Protein urine present—Esomeprazole—Barrett's esophagus	0.00176	0.0104	CcSEcCtD
Sulindac—Protein urine present—Omeprazole—Barrett's esophagus	0.00176	0.0104	CcSEcCtD
Sulindac—Glossitis—Omeprazole—Barrett's esophagus	0.0017	0.0101	CcSEcCtD
Sulindac—Glossitis—Esomeprazole—Barrett's esophagus	0.0017	0.0101	CcSEcCtD
Sulindac—Leukocytosis—Omeprazole—Barrett's esophagus	0.00167	0.00987	CcSEcCtD
Sulindac—Leukocytosis—Esomeprazole—Barrett's esophagus	0.00167	0.00987	CcSEcCtD
Sulindac—Gynaecomastia—Omeprazole—Barrett's esophagus	0.0014	0.0083	CcSEcCtD
Sulindac—Gynaecomastia—Esomeprazole—Barrett's esophagus	0.0014	0.0083	CcSEcCtD
Sulindac—Photosensitivity—Omeprazole—Barrett's esophagus	0.0013	0.00767	CcSEcCtD
Sulindac—Photosensitivity—Esomeprazole—Barrett's esophagus	0.0013	0.00767	CcSEcCtD
Sulindac—Gastroenteritis—Esomeprazole—Barrett's esophagus	0.00129	0.0076	CcSEcCtD
Sulindac—Gastroenteritis—Omeprazole—Barrett's esophagus	0.00129	0.0076	CcSEcCtD
Sulindac—Vascular purpura—Omeprazole—Barrett's esophagus	0.00127	0.00753	CcSEcCtD
Sulindac—Vascular purpura—Esomeprazole—Barrett's esophagus	0.00127	0.00753	CcSEcCtD
Sulindac—Hepatic failure—Omeprazole—Barrett's esophagus	0.00127	0.00749	CcSEcCtD
Sulindac—Hepatic failure—Esomeprazole—Barrett's esophagus	0.00127	0.00749	CcSEcCtD
Sulindac—Haemolytic anaemia—Omeprazole—Barrett's esophagus	0.00126	0.00746	CcSEcCtD
Sulindac—Haemolytic anaemia—Esomeprazole—Barrett's esophagus	0.00126	0.00746	CcSEcCtD
Sulindac—CYP1A1—epithelium—Barrett's esophagus	0.00121	0.0261	CbGeAlD
Sulindac—Visual disturbance—Esomeprazole—Barrett's esophagus	0.0012	0.00711	CcSEcCtD
Sulindac—Visual disturbance—Omeprazole—Barrett's esophagus	0.0012	0.00711	CcSEcCtD
Sulindac—Renal impairment—Esomeprazole—Barrett's esophagus	0.0012	0.00708	CcSEcCtD
Sulindac—Renal impairment—Omeprazole—Barrett's esophagus	0.0012	0.00708	CcSEcCtD
Sulindac—Purpura—Esomeprazole—Barrett's esophagus	0.00118	0.00699	CcSEcCtD
Sulindac—Purpura—Omeprazole—Barrett's esophagus	0.00118	0.00699	CcSEcCtD
Sulindac—Arthritis—Esomeprazole—Barrett's esophagus	0.00117	0.00693	CcSEcCtD
Sulindac—Arthritis—Omeprazole—Barrett's esophagus	0.00117	0.00693	CcSEcCtD
Sulindac—Gastrointestinal haemorrhage—Omeprazole—Barrett's esophagus	0.00114	0.00673	CcSEcCtD
Sulindac—Gastrointestinal haemorrhage—Esomeprazole—Barrett's esophagus	0.00114	0.00673	CcSEcCtD
Sulindac—PTGS1—epithelium—Barrett's esophagus	0.00106	0.023	CbGeAlD
Sulindac—Toxic epidermal necrolysis—Esomeprazole—Barrett's esophagus	0.00103	0.00606	CcSEcCtD
Sulindac—Toxic epidermal necrolysis—Omeprazole—Barrett's esophagus	0.00103	0.00606	CcSEcCtD
Sulindac—PTGS1—smooth muscle tissue—Barrett's esophagus	0.00102	0.0221	CbGeAlD
Sulindac—PTGS2—epithelium—Barrett's esophagus	0.00101	0.0219	CbGeAlD
Sulindac—Gastritis—Omeprazole—Barrett's esophagus	0.00101	0.00596	CcSEcCtD
Sulindac—Gastritis—Esomeprazole—Barrett's esophagus	0.00101	0.00596	CcSEcCtD
Sulindac—Muscular weakness—Omeprazole—Barrett's esophagus	0.00101	0.00594	CcSEcCtD
Sulindac—Muscular weakness—Esomeprazole—Barrett's esophagus	0.00101	0.00594	CcSEcCtD
Sulindac—PTGS2—smooth muscle tissue—Barrett's esophagus	0.000976	0.0211	CbGeAlD
Sulindac—Bronchospasm—Esomeprazole—Barrett's esophagus	0.000969	0.00573	CcSEcCtD
Sulindac—Bronchospasm—Omeprazole—Barrett's esophagus	0.000969	0.00573	CcSEcCtD
Sulindac—Pancreatitis—Omeprazole—Barrett's esophagus	0.000966	0.00571	CcSEcCtD
Sulindac—Pancreatitis—Esomeprazole—Barrett's esophagus	0.000966	0.00571	CcSEcCtD
Sulindac—Sweating increased—Esomeprazole—Barrett's esophagus	0.00096	0.00567	CcSEcCtD
Sulindac—Sweating increased—Omeprazole—Barrett's esophagus	0.00096	0.00567	CcSEcCtD
Sulindac—Pancytopenia—Omeprazole—Barrett's esophagus	0.000936	0.00553	CcSEcCtD
Sulindac—Pancytopenia—Esomeprazole—Barrett's esophagus	0.000936	0.00553	CcSEcCtD
Sulindac—CYP1A2—digestive system—Barrett's esophagus	0.00093	0.0202	CbGeAlD
Sulindac—Neutropenia—Esomeprazole—Barrett's esophagus	0.000921	0.00544	CcSEcCtD
Sulindac—Dysuria—Omeprazole—Barrett's esophagus	0.000921	0.00544	CcSEcCtD
Sulindac—Neutropenia—Omeprazole—Barrett's esophagus	0.000921	0.00544	CcSEcCtD
Sulindac—Dysuria—Esomeprazole—Barrett's esophagus	0.000921	0.00544	CcSEcCtD
Sulindac—CYP1A1—digestive system—Barrett's esophagus	0.000917	0.0199	CbGeAlD
Sulindac—Photosensitivity reaction—Omeprazole—Barrett's esophagus	0.000899	0.00531	CcSEcCtD
Sulindac—Photosensitivity reaction—Esomeprazole—Barrett's esophagus	0.000899	0.00531	CcSEcCtD
Sulindac—Depression—Esomeprazole—Barrett's esophagus	0.000876	0.00517	CcSEcCtD
Sulindac—Depression—Omeprazole—Barrett's esophagus	0.000876	0.00517	CcSEcCtD
Sulindac—Stevens-Johnson syndrome—Esomeprazole—Barrett's esophagus	0.000871	0.00515	CcSEcCtD
Sulindac—Stevens-Johnson syndrome—Omeprazole—Barrett's esophagus	0.000871	0.00515	CcSEcCtD
Sulindac—Renal failure—Esomeprazole—Barrett's esophagus	0.000863	0.0051	CcSEcCtD
Sulindac—Renal failure—Omeprazole—Barrett's esophagus	0.000863	0.0051	CcSEcCtD
Sulindac—Jaundice—Omeprazole—Barrett's esophagus	0.000856	0.00506	CcSEcCtD
Sulindac—Stomatitis—Esomeprazole—Barrett's esophagus	0.000856	0.00506	CcSEcCtD
Sulindac—Jaundice—Esomeprazole—Barrett's esophagus	0.000856	0.00506	CcSEcCtD
Sulindac—Stomatitis—Omeprazole—Barrett's esophagus	0.000856	0.00506	CcSEcCtD
Sulindac—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.000854	0.00504	CcSEcCtD
Sulindac—Conjunctivitis—Omeprazole—Barrett's esophagus	0.000854	0.00504	CcSEcCtD
Sulindac—Haematuria—Omeprazole—Barrett's esophagus	0.000838	0.00495	CcSEcCtD
Sulindac—Haematuria—Esomeprazole—Barrett's esophagus	0.000838	0.00495	CcSEcCtD
Sulindac—Epistaxis—Esomeprazole—Barrett's esophagus	0.000829	0.00489	CcSEcCtD
Sulindac—Epistaxis—Omeprazole—Barrett's esophagus	0.000829	0.00489	CcSEcCtD
Sulindac—Agranulocytosis—Esomeprazole—Barrett's esophagus	0.00082	0.00484	CcSEcCtD
Sulindac—Agranulocytosis—Omeprazole—Barrett's esophagus	0.00082	0.00484	CcSEcCtD
Sulindac—PTGS1—digestive system—Barrett's esophagus	0.000806	0.0175	CbGeAlD
Sulindac—Hepatitis—Esomeprazole—Barrett's esophagus	0.000789	0.00466	CcSEcCtD
Sulindac—Hepatitis—Omeprazole—Barrett's esophagus	0.000789	0.00466	CcSEcCtD
Sulindac—PTGS2—digestive system—Barrett's esophagus	0.00077	0.0167	CbGeAlD
Sulindac—Visual impairment—Esomeprazole—Barrett's esophagus	0.00076	0.00449	CcSEcCtD
Sulindac—Visual impairment—Omeprazole—Barrett's esophagus	0.00076	0.00449	CcSEcCtD
Sulindac—Erythema multiforme—Omeprazole—Barrett's esophagus	0.000746	0.0044	CcSEcCtD
Sulindac—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.000746	0.0044	CcSEcCtD
Sulindac—Tinnitus—Omeprazole—Barrett's esophagus	0.000735	0.00434	CcSEcCtD
Sulindac—Tinnitus—Esomeprazole—Barrett's esophagus	0.000735	0.00434	CcSEcCtD
Sulindac—Flushing—Esomeprazole—Barrett's esophagus	0.000732	0.00432	CcSEcCtD
Sulindac—Flushing—Omeprazole—Barrett's esophagus	0.000732	0.00432	CcSEcCtD
Sulindac—Chills—Esomeprazole—Barrett's esophagus	0.000708	0.00418	CcSEcCtD
Sulindac—Chills—Omeprazole—Barrett's esophagus	0.000708	0.00418	CcSEcCtD
Sulindac—Alopecia—Esomeprazole—Barrett's esophagus	0.000697	0.00412	CcSEcCtD
Sulindac—Alopecia—Omeprazole—Barrett's esophagus	0.000697	0.00412	CcSEcCtD
Sulindac—Flatulence—Omeprazole—Barrett's esophagus	0.000676	0.004	CcSEcCtD
Sulindac—Flatulence—Esomeprazole—Barrett's esophagus	0.000676	0.004	CcSEcCtD
Sulindac—Tension—Esomeprazole—Barrett's esophagus	0.000674	0.00398	CcSEcCtD
Sulindac—Tension—Omeprazole—Barrett's esophagus	0.000674	0.00398	CcSEcCtD
Sulindac—Dysgeusia—Omeprazole—Barrett's esophagus	0.000672	0.00397	CcSEcCtD
Sulindac—Dysgeusia—Esomeprazole—Barrett's esophagus	0.000672	0.00397	CcSEcCtD
Sulindac—Nervousness—Omeprazole—Barrett's esophagus	0.000667	0.00394	CcSEcCtD
Sulindac—Nervousness—Esomeprazole—Barrett's esophagus	0.000667	0.00394	CcSEcCtD
Sulindac—Vision blurred—Esomeprazole—Barrett's esophagus	0.000647	0.00382	CcSEcCtD
Sulindac—Vision blurred—Omeprazole—Barrett's esophagus	0.000647	0.00382	CcSEcCtD
Sulindac—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.000637	0.00376	CcSEcCtD
Sulindac—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.000637	0.00376	CcSEcCtD
Sulindac—Anaemia—Esomeprazole—Barrett's esophagus	0.000634	0.00375	CcSEcCtD
Sulindac—Anaemia—Omeprazole—Barrett's esophagus	0.000634	0.00375	CcSEcCtD
Sulindac—Angioedema—Omeprazole—Barrett's esophagus	0.000627	0.00371	CcSEcCtD
Sulindac—Angioedema—Esomeprazole—Barrett's esophagus	0.000627	0.00371	CcSEcCtD
Sulindac—Malaise—Esomeprazole—Barrett's esophagus	0.000619	0.00366	CcSEcCtD
Sulindac—Malaise—Omeprazole—Barrett's esophagus	0.000619	0.00366	CcSEcCtD
Sulindac—Vertigo—Esomeprazole—Barrett's esophagus	0.000617	0.00364	CcSEcCtD
Sulindac—Vertigo—Omeprazole—Barrett's esophagus	0.000617	0.00364	CcSEcCtD
Sulindac—Leukopenia—Omeprazole—Barrett's esophagus	0.000614	0.00363	CcSEcCtD
Sulindac—Leukopenia—Esomeprazole—Barrett's esophagus	0.000614	0.00363	CcSEcCtD
Sulindac—Palpitations—Omeprazole—Barrett's esophagus	0.000607	0.00358	CcSEcCtD
Sulindac—Palpitations—Esomeprazole—Barrett's esophagus	0.000607	0.00358	CcSEcCtD
Sulindac—Hypertension—Omeprazole—Barrett's esophagus	0.000593	0.0035	CcSEcCtD
Sulindac—Hypertension—Esomeprazole—Barrett's esophagus	0.000593	0.0035	CcSEcCtD
Sulindac—Arthralgia—Esomeprazole—Barrett's esophagus	0.000584	0.00345	CcSEcCtD
Sulindac—Chest pain—Esomeprazole—Barrett's esophagus	0.000584	0.00345	CcSEcCtD
Sulindac—Myalgia—Esomeprazole—Barrett's esophagus	0.000584	0.00345	CcSEcCtD
Sulindac—Arthralgia—Omeprazole—Barrett's esophagus	0.000584	0.00345	CcSEcCtD
Sulindac—Chest pain—Omeprazole—Barrett's esophagus	0.000584	0.00345	CcSEcCtD
Sulindac—Myalgia—Omeprazole—Barrett's esophagus	0.000584	0.00345	CcSEcCtD
Sulindac—Discomfort—Esomeprazole—Barrett's esophagus	0.000577	0.00341	CcSEcCtD
Sulindac—Discomfort—Omeprazole—Barrett's esophagus	0.000577	0.00341	CcSEcCtD
Sulindac—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.00056	0.00331	CcSEcCtD
Sulindac—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.00056	0.00331	CcSEcCtD
Sulindac—Shock—Omeprazole—Barrett's esophagus	0.000551	0.00326	CcSEcCtD
Sulindac—Shock—Esomeprazole—Barrett's esophagus	0.000551	0.00326	CcSEcCtD
Sulindac—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.000549	0.00324	CcSEcCtD
Sulindac—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.000549	0.00324	CcSEcCtD
Sulindac—Tachycardia—Esomeprazole—Barrett's esophagus	0.000547	0.00323	CcSEcCtD
Sulindac—Tachycardia—Omeprazole—Barrett's esophagus	0.000547	0.00323	CcSEcCtD
Sulindac—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000543	0.0061	CbGpPWpGaD
Sulindac—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000543	0.0061	CbGpPWpGaD
Sulindac—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.000542	0.0032	CcSEcCtD
Sulindac—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.000542	0.0032	CcSEcCtD
Sulindac—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00054	0.00607	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism—PTGES—Barrett's esophagus	0.000538	0.00604	CbGpPWpGaD
Sulindac—Anorexia—Omeprazole—Barrett's esophagus	0.000534	0.00316	CcSEcCtD
Sulindac—Anorexia—Esomeprazole—Barrett's esophagus	0.000534	0.00316	CcSEcCtD
Sulindac—CYP1A1—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000533	0.00599	CbGpPWpGaD
Sulindac—CYP1A2—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000526	0.00591	CbGpPWpGaD
Sulindac—MAPK3—FGF signaling pathway—HGF—Barrett's esophagus	0.000511	0.00575	CbGpPWpGaD
Sulindac—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.00051	0.00302	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.00051	0.00302	CcSEcCtD
Sulindac—Insomnia—Esomeprazole—Barrett's esophagus	0.000507	0.00299	CcSEcCtD
Sulindac—Insomnia—Omeprazole—Barrett's esophagus	0.000507	0.00299	CcSEcCtD
Sulindac—Paraesthesia—Omeprazole—Barrett's esophagus	0.000503	0.00297	CcSEcCtD
Sulindac—Paraesthesia—Esomeprazole—Barrett's esophagus	0.000503	0.00297	CcSEcCtD
Sulindac—Dyspnoea—Omeprazole—Barrett's esophagus	0.000499	0.00295	CcSEcCtD
Sulindac—Dyspnoea—Esomeprazole—Barrett's esophagus	0.000499	0.00295	CcSEcCtD
Sulindac—Somnolence—Omeprazole—Barrett's esophagus	0.000498	0.00294	CcSEcCtD
Sulindac—Somnolence—Esomeprazole—Barrett's esophagus	0.000498	0.00294	CcSEcCtD
Sulindac—PTGS1—Overview of nanoparticle effects—PTGS2—Barrett's esophagus	0.000498	0.0056	CbGpPWpGaD
Sulindac—MAPK3—Oncogene Induced Senescence—CDKN2A—Barrett's esophagus	0.000493	0.00554	CbGpPWpGaD
Sulindac—Dyspepsia—Omeprazole—Barrett's esophagus	0.000493	0.00291	CcSEcCtD
Sulindac—Dyspepsia—Esomeprazole—Barrett's esophagus	0.000493	0.00291	CcSEcCtD
Sulindac—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000487	0.00288	CcSEcCtD
Sulindac—Decreased appetite—Omeprazole—Barrett's esophagus	0.000487	0.00288	CcSEcCtD
Sulindac—Fatigue—Omeprazole—Barrett's esophagus	0.000483	0.00285	CcSEcCtD
Sulindac—Fatigue—Esomeprazole—Barrett's esophagus	0.000483	0.00285	CcSEcCtD
Sulindac—PTGS1—Overview of nanoparticle effects—CXCL8—Barrett's esophagus	0.000483	0.00543	CbGpPWpGaD
Sulindac—Constipation—Omeprazole—Barrett's esophagus	0.000479	0.00283	CcSEcCtD
Sulindac—Constipation—Esomeprazole—Barrett's esophagus	0.000479	0.00283	CcSEcCtD
Sulindac—MAPK3—ErbB1 downstream signaling—SLC9A1—Barrett's esophagus	0.000472	0.0053	CbGpPWpGaD
Sulindac—PTGDR2—GPCR ligand binding—SST—Barrett's esophagus	0.000467	0.00525	CbGpPWpGaD
Sulindac—MAPK3—Osteopontin-mediated events—RELA—Barrett's esophagus	0.000462	0.0052	CbGpPWpGaD
Sulindac—MAPK3—IL17 signaling pathway—RELA—Barrett's esophagus	0.000462	0.0052	CbGpPWpGaD
Sulindac—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.000462	0.00273	CcSEcCtD
Sulindac—Feeling abnormal—Omeprazole—Barrett's esophagus	0.000462	0.00273	CcSEcCtD
Sulindac—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000458	0.00271	CcSEcCtD
Sulindac—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000458	0.00271	CcSEcCtD
Sulindac—PPARD—NRF2 pathway—HGF—Barrett's esophagus	0.000452	0.00508	CbGpPWpGaD
Sulindac—PPARD—Wnt Signaling Pathway and Pluripotency—APC—Barrett's esophagus	0.000447	0.00502	CbGpPWpGaD
Sulindac—Urticaria—Esomeprazole—Barrett's esophagus	0.000445	0.00263	CcSEcCtD
Sulindac—Urticaria—Omeprazole—Barrett's esophagus	0.000445	0.00263	CcSEcCtD
Sulindac—Body temperature increased—Omeprazole—Barrett's esophagus	0.000443	0.00262	CcSEcCtD
Sulindac—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000443	0.00262	CcSEcCtD
Sulindac—CYP1A1—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000438	0.00492	CbGpPWpGaD
Sulindac—PPARD—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000437	0.00492	CbGpPWpGaD
Sulindac—MAPK3—Presenilin action in Notch and Wnt signaling—APC—Barrett's esophagus	0.000432	0.00485	CbGpPWpGaD
Sulindac—PTGS1—Eicosanoid Synthesis—PTGS2—Barrett's esophagus	0.000413	0.00464	CbGpPWpGaD
Sulindac—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000413	0.00244	CcSEcCtD
Sulindac—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000413	0.00244	CcSEcCtD
Sulindac—AKR1B1—Metabolism—CYP26A1—Barrett's esophagus	0.000408	0.00458	CbGpPWpGaD
Sulindac—Asthenia—Omeprazole—Barrett's esophagus	0.000402	0.00237	CcSEcCtD
Sulindac—Asthenia—Esomeprazole—Barrett's esophagus	0.000402	0.00237	CcSEcCtD
Sulindac—Pruritus—Esomeprazole—Barrett's esophagus	0.000396	0.00234	CcSEcCtD
Sulindac—Pruritus—Omeprazole—Barrett's esophagus	0.000396	0.00234	CcSEcCtD
Sulindac—PPARD—Generic Transcription Pathway—NR1I2—Barrett's esophagus	0.000394	0.00443	CbGpPWpGaD
Sulindac—MAPK3—Syndecan-2-mediated signaling events—CXCL8—Barrett's esophagus	0.000387	0.00435	CbGpPWpGaD
Sulindac—PTGDR2—GPCR downstream signaling—GAST—Barrett's esophagus	0.000385	0.00433	CbGpPWpGaD
Sulindac—PTGS2—Overview of nanoparticle effects—CXCL8—Barrett's esophagus	0.000383	0.00431	CbGpPWpGaD
Sulindac—Diarrhoea—Omeprazole—Barrett's esophagus	0.000383	0.00226	CcSEcCtD
Sulindac—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000383	0.00226	CcSEcCtD
Sulindac—MAPK3—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HGF—Barrett's esophagus	0.000373	0.0042	CbGpPWpGaD
Sulindac—Dizziness—Esomeprazole—Barrett's esophagus	0.00037	0.00219	CcSEcCtD
Sulindac—Dizziness—Omeprazole—Barrett's esophagus	0.00037	0.00219	CcSEcCtD
Sulindac—MAPK3—TWEAK Signaling Pathway—RELA—Barrett's esophagus	0.000363	0.00408	CbGpPWpGaD
Sulindac—MAPK3—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.000356	0.004	CbGpPWpGaD
Sulindac—Vomiting—Omeprazole—Barrett's esophagus	0.000356	0.0021	CcSEcCtD
Sulindac—Vomiting—Esomeprazole—Barrett's esophagus	0.000356	0.0021	CcSEcCtD
Sulindac—PPARD—Adipogenesis—PPARG—Barrett's esophagus	0.000355	0.00399	CbGpPWpGaD
Sulindac—Rash—Omeprazole—Barrett's esophagus	0.000353	0.00209	CcSEcCtD
Sulindac—Rash—Esomeprazole—Barrett's esophagus	0.000353	0.00209	CcSEcCtD
Sulindac—Dermatitis—Omeprazole—Barrett's esophagus	0.000353	0.00209	CcSEcCtD
Sulindac—Dermatitis—Esomeprazole—Barrett's esophagus	0.000353	0.00209	CcSEcCtD
Sulindac—Headache—Esomeprazole—Barrett's esophagus	0.000351	0.00207	CcSEcCtD
Sulindac—Headache—Omeprazole—Barrett's esophagus	0.000351	0.00207	CcSEcCtD
Sulindac—PTGDR2—Signaling by GPCR—GAST—Barrett's esophagus	0.00035	0.00393	CbGpPWpGaD
Sulindac—MAPK3—Interleukin-11 Signaling Pathway—RELA—Barrett's esophagus	0.000349	0.00393	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.000347	0.0039	CbGpPWpGaD
Sulindac—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—Barrett's esophagus	0.000346	0.00388	CbGpPWpGaD
Sulindac—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000344	0.00387	CbGpPWpGaD
Sulindac—CYP1A2—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.00034	0.00382	CbGpPWpGaD
Sulindac—Nausea—Omeprazole—Barrett's esophagus	0.000333	0.00197	CcSEcCtD
Sulindac—Nausea—Esomeprazole—Barrett's esophagus	0.000333	0.00197	CcSEcCtD
Sulindac—MAPK3—Structural Pathway of Interleukin 1 (IL-1)—RELA—Barrett's esophagus	0.000332	0.00373	CbGpPWpGaD
Sulindac—MAPK3—TSLP Signaling Pathway—RELA—Barrett's esophagus	0.000332	0.00373	CbGpPWpGaD
Sulindac—PTGS1—Biological oxidations—CYP26A1—Barrett's esophagus	0.00033	0.00371	CbGpPWpGaD
Sulindac—MAPK3—Ceramide signaling pathway—RELA—Barrett's esophagus	0.000326	0.00366	CbGpPWpGaD
Sulindac—MAPK3—Angiopoietin receptor Tie2-mediated signaling—RELA—Barrett's esophagus	0.000315	0.00355	CbGpPWpGaD
Sulindac—MAPK3—TSLP Signaling Pathway—CXCL8—Barrett's esophagus	0.000312	0.00351	CbGpPWpGaD
Sulindac—MAPK3—CDC42 signaling events—APC—Barrett's esophagus	0.000308	0.00347	CbGpPWpGaD
Sulindac—MAPK3—IL-3 Signaling Pathway—CXCL8—Barrett's esophagus	0.000302	0.0034	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	0.000301	0.00338	CbGpPWpGaD
Sulindac—PTGDR2—G alpha (i) signalling events—CXCL8—Barrett's esophagus	0.0003	0.00338	CbGpPWpGaD
Sulindac—MAPK3—IL-4 Signaling Pathway—RELA—Barrett's esophagus	0.000297	0.00333	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism—SLC9A1—Barrett's esophagus	0.000294	0.0033	CbGpPWpGaD
Sulindac—MAPK3—Signaling by Interleukins—HGF—Barrett's esophagus	0.000294	0.0033	CbGpPWpGaD
Sulindac—MAPK3—IL-1 signaling pathway—RELA—Barrett's esophagus	0.000292	0.00328	CbGpPWpGaD
Sulindac—MAPK3—RANKL/RANK Signaling Pathway—RELA—Barrett's esophagus	0.000292	0.00328	CbGpPWpGaD
Sulindac—CYP1A2—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000279	0.00314	CbGpPWpGaD
Sulindac—MAPK3—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—APC—Barrett's esophagus	0.000277	0.00312	CbGpPWpGaD
Sulindac—MAPK3—Oncogene Induced Senescence—TP53—Barrett's esophagus	0.000275	0.00309	CbGpPWpGaD
Sulindac—PPARD—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—Barrett's esophagus	0.000274	0.00308	CbGpPWpGaD
Sulindac—MAPK3—Fc-epsilon receptor I signaling in mast cells—RELA—Barrett's esophagus	0.000269	0.00302	CbGpPWpGaD
Sulindac—PTGDR2—GPCR downstream signaling—SST—Barrett's esophagus	0.000264	0.00296	CbGpPWpGaD
Sulindac—MAPK3—ATF-2 transcription factor network—CXCL8—Barrett's esophagus	0.00026	0.00293	CbGpPWpGaD
Sulindac—MAPK3—Oncostatin M Signaling Pathway—RELA—Barrett's esophagus	0.000256	0.00287	CbGpPWpGaD
Sulindac—MAPK3—AGE/RAGE pathway—RELA—Barrett's esophagus	0.000253	0.00284	CbGpPWpGaD
Sulindac—MAPK3—BCR signaling pathway—RELA—Barrett's esophagus	0.00025	0.00281	CbGpPWpGaD
Sulindac—MAPK3—Rac1/Pak1/p38/MMP-2 pathway—RELA—Barrett's esophagus	0.00025	0.00281	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—SST—Barrett's esophagus	0.00024	0.00269	CbGpPWpGaD
Sulindac—PTGDR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	0.000239	0.00268	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	0.000237	0.00266	CbGpPWpGaD
Sulindac—CYP1A1—Biological oxidations—CYP26A1—Barrett's esophagus	0.000233	0.00261	CbGpPWpGaD
Sulindac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—Barrett's esophagus	0.000232	0.0026	CbGpPWpGaD
Sulindac—PTGS1—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.00023	0.00258	CbGpPWpGaD
Sulindac—CYP1A1—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000229	0.00258	CbGpPWpGaD
Sulindac—MAPK3—Leptin signaling pathway—RELA—Barrett's esophagus	0.000228	0.00256	CbGpPWpGaD
Sulindac—MAPK3—TRAF6 Mediated Induction of proinflammatory cytokines—RELA—Barrett's esophagus	0.000228	0.00256	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways in Glioblastoma—CDKN2A—Barrett's esophagus	0.000221	0.00248	CbGpPWpGaD
Sulindac—MAPK3—Glucocorticoid receptor regulatory network—RELA—Barrett's esophagus	0.000212	0.00239	CbGpPWpGaD
Sulindac—SLC22A6—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	0.000211	0.00237	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—GAST—Barrett's esophagus	0.000206	0.00232	CbGpPWpGaD
Sulindac—MAPK3—MyD88 cascade initiated on plasma membrane—RELA—Barrett's esophagus	0.000206	0.00232	CbGpPWpGaD
Sulindac—MAPK3—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—RELA—Barrett's esophagus	0.000204	0.0023	CbGpPWpGaD
Sulindac—MAPK3—Apoptosis Modulation and Signaling—CDKN2A—Barrett's esophagus	0.000203	0.00228	CbGpPWpGaD
Sulindac—PPARD—Wnt Signaling Pathway and Pluripotency—TP53—Barrett's esophagus	0.000202	0.00227	CbGpPWpGaD
Sulindac—MAPK3—MyD88 dependent cascade initiated on endosome—RELA—Barrett's esophagus	0.000201	0.00226	CbGpPWpGaD
Sulindac—PTGS2—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	0.000201	0.00225	CbGpPWpGaD
Sulindac—MAPK3—Glucocorticoid receptor regulatory network—CXCL8—Barrett's esophagus	0.0002	0.00225	CbGpPWpGaD
Sulindac—MAPK3—TCR Signaling Pathway—RELA—Barrett's esophagus	0.000197	0.00222	CbGpPWpGaD
Sulindac—PPARD—Metabolism—PTGES—Barrett's esophagus	0.000195	0.00219	CbGpPWpGaD
Sulindac—MAPK3—Corticotropin-releasing hormone—RELA—Barrett's esophagus	0.000194	0.00218	CbGpPWpGaD
Sulindac—MAPK3—Toll Like Receptor 9 (TLR9) Cascade—RELA—Barrett's esophagus	0.000194	0.00218	CbGpPWpGaD
Sulindac—MAPK3—MyD88:Mal cascade initiated on plasma membrane—RELA—Barrett's esophagus	0.00019	0.00214	CbGpPWpGaD
Sulindac—PPARD—Gene Expression—NR1I2—Barrett's esophagus	0.00019	0.00213	CbGpPWpGaD
Sulindac—MAPK3—MyD88-independent cascade—RELA—Barrett's esophagus	0.000183	0.00205	CbGpPWpGaD
Sulindac—MAPK3—Corticotropin-releasing hormone—CXCL8—Barrett's esophagus	0.000183	0.00205	CbGpPWpGaD
Sulindac—PTGDR2—GPCR ligand binding—CXCL8—Barrett's esophagus	0.000182	0.00204	CbGpPWpGaD
Sulindac—MAPK3—Senescence-Associated Secretory Phenotype (SASP)—CDKN2A—Barrett's esophagus	0.000181	0.00203	CbGpPWpGaD
Sulindac—ALB—Platelet degranulation—HGF—Barrett's esophagus	0.00018	0.00202	CbGpPWpGaD
Sulindac—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000179	0.00201	CbGpPWpGaD
Sulindac—MAPK3—Toll-like Receptor Signaling Pathway—RELA—Barrett's esophagus	0.000178	0.002	CbGpPWpGaD
Sulindac—CYP1A1—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	0.000178	0.002	CbGpPWpGaD
Sulindac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Barrett's esophagus	0.000177	0.00199	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000175	0.00197	CbGpPWpGaD
Sulindac—MAPK3—Senescence-Associated Secretory Phenotype (SASP)—RELA—Barrett's esophagus	0.000174	0.00196	CbGpPWpGaD
Sulindac—MAPK3—BDNF signaling pathway—APC—Barrett's esophagus	0.000173	0.00195	CbGpPWpGaD
Sulindac—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	0.000173	0.00194	CbGpPWpGaD
Sulindac—ALB—Response to elevated platelet cytosolic Ca2+—HGF—Barrett's esophagus	0.000171	0.00192	CbGpPWpGaD
Sulindac—MAPK3—Signaling by Interleukins—RELA—Barrett's esophagus	0.00017	0.00191	CbGpPWpGaD
Sulindac—MAPK3—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.000169	0.00189	CbGpPWpGaD
Sulindac—MAPK3—Toll-like Receptor Signaling Pathway—CXCL8—Barrett's esophagus	0.000168	0.00189	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000167	0.00188	CbGpPWpGaD
Sulindac—MAPK3—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	0.000166	0.00186	CbGpPWpGaD
Sulindac—MAPK3—Activated TLR4 signalling—RELA—Barrett's esophagus	0.000164	0.00185	CbGpPWpGaD
Sulindac—MAPK3—Senescence-Associated Secretory Phenotype (SASP)—CXCL8—Barrett's esophagus	0.000164	0.00185	CbGpPWpGaD
Sulindac—MAPK3—Oxidative Stress Induced Senescence—CDKN2A—Barrett's esophagus	0.000164	0.00184	CbGpPWpGaD
Sulindac—CYP1A1—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000162	0.00182	CbGpPWpGaD
Sulindac—MAPK3—Toll Like Receptor 4 (TLR4) Cascade—RELA—Barrett's esophagus	0.000155	0.00174	CbGpPWpGaD
Sulindac—MAPK3—Spinal Cord Injury—PTGS2—Barrett's esophagus	0.000154	0.00173	CbGpPWpGaD
Sulindac—PTGS1—Selenium Micronutrient Network—RELA—Barrett's esophagus	0.00015	0.00169	CbGpPWpGaD
Sulindac—MAPK3—Spinal Cord Injury—CXCL8—Barrett's esophagus	0.00015	0.00168	CbGpPWpGaD
Sulindac—ALB—Vitamin B12 Metabolism—RELA—Barrett's esophagus	0.000149	0.00168	CbGpPWpGaD
Sulindac—CYP1A2—Biological oxidations—CYP26A1—Barrett's esophagus	0.000148	0.00167	CbGpPWpGaD
Sulindac—MAPK3—Oncostatin M Signaling Pathway—TP53—Barrett's esophagus	0.000148	0.00166	CbGpPWpGaD
Sulindac—PPARD—Metabolism—CYP26A1—Barrett's esophagus	0.000148	0.00166	CbGpPWpGaD
Sulindac—CYP1A2—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000146	0.00164	CbGpPWpGaD
Sulindac—PTGS1—Selenium Micronutrient Network—PTGS2—Barrett's esophagus	0.000146	0.00164	CbGpPWpGaD
Sulindac—MAPK3—Rac1/Pak1/p38/MMP-2 pathway—TP53—Barrett's esophagus	0.000144	0.00162	CbGpPWpGaD
Sulindac—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—Barrett's esophagus	0.000144	0.00162	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—SST—Barrett's esophagus	0.000142	0.00159	CbGpPWpGaD
Sulindac—MAPK3—Regulation of toll-like receptor signaling pathway—RELA—Barrett's esophagus	0.000139	0.00156	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000138	0.00155	CbGpPWpGaD
Sulindac—MAPK3—Toll-Like Receptors Cascades—RELA—Barrett's esophagus	0.000138	0.00155	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—HGF—Barrett's esophagus	0.000137	0.00154	CbGpPWpGaD
Sulindac—MAPK3—BDNF signaling pathway—RELA—Barrett's esophagus	0.000135	0.00152	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism—PPARG—Barrett's esophagus	0.000134	0.00151	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000133	0.00149	CbGpPWpGaD
Sulindac—MAPK3—Regulation of toll-like receptor signaling pathway—CXCL8—Barrett's esophagus	0.000131	0.00147	CbGpPWpGaD
Sulindac—PPARD—Generic Transcription Pathway—PPARG—Barrett's esophagus	0.00013	0.00146	CbGpPWpGaD
Sulindac—PTGS2—C-MYB transcription factor network—CDKN2A—Barrett's esophagus	0.000129	0.00145	CbGpPWpGaD
Sulindac—MAPK3—Alzheimers Disease—TP53—Barrett's esophagus	0.000127	0.00142	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways in Glioblastoma—TP53—Barrett's esophagus	0.000123	0.00138	CbGpPWpGaD
Sulindac—MAPK3—Glucocorticoid receptor regulatory network—TP53—Barrett's esophagus	0.000123	0.00138	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—RELA—Barrett's esophagus	0.000122	0.00137	CbGpPWpGaD
Sulindac—PTGS2—Selenium Micronutrient Network—RELA—Barrett's esophagus	0.000119	0.00134	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000118	0.00132	CbGpPWpGaD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	0.000115	0.00129	CbGpPWpGaD
Sulindac—MAPK3—Cellular Senescence—CDKN2A—Barrett's esophagus	0.000115	0.00129	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	0.000113	0.00128	CbGpPWpGaD
Sulindac—MAPK3—Apoptosis Modulation and Signaling—TP53—Barrett's esophagus	0.000113	0.00127	CbGpPWpGaD
Sulindac—MAPK3—Cellular Senescence—RELA—Barrett's esophagus	0.00011	0.00124	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	0.00011	0.00124	CbGpPWpGaD
Sulindac—ALB—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	0.00011	0.00123	CbGpPWpGaD
Sulindac—CYP1A1—PPARA activates gene expression—PPARG—Barrett's esophagus	0.000109	0.00123	CbGpPWpGaD
Sulindac—PPARD—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	0.000109	0.00123	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000107	0.00121	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000107	0.00121	CbGpPWpGaD
Sulindac—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—Barrett's esophagus	0.000107	0.0012	CbGpPWpGaD
Sulindac—PPARD—Metabolism—SLC9A1—Barrett's esophagus	0.000106	0.0012	CbGpPWpGaD
Sulindac—AKR1B1—Metabolism—PTGS2—Barrett's esophagus	0.000106	0.00119	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000105	0.00118	CbGpPWpGaD
Sulindac—MAPK3—Cellular Senescence—CXCL8—Barrett's esophagus	0.000104	0.00117	CbGpPWpGaD
Sulindac—CYP1A2—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000103	0.00116	CbGpPWpGaD
Sulindac—PTGDR2—GPCR downstream signaling—CXCL8—Barrett's esophagus	0.000103	0.00115	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—GAST—Barrett's esophagus	0.0001	0.00113	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—NR1I2—Barrett's esophagus	9.69e-05	0.00109	CbGpPWpGaD
Sulindac—ALB—Selenium Micronutrient Network—RELA—Barrett's esophagus	9.66e-05	0.00109	CbGpPWpGaD
Sulindac—ALB—Selenium Micronutrient Network—PTGS2—Barrett's esophagus	9.38e-05	0.00105	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—CXCL8—Barrett's esophagus	9.33e-05	0.00105	CbGpPWpGaD
Sulindac—MAPK3—Spinal Cord Injury—TP53—Barrett's esophagus	9.18e-05	0.00103	CbGpPWpGaD
Sulindac—MAPK3—Oxidative Stress Induced Senescence—TP53—Barrett's esophagus	9.12e-05	0.00102	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	9.11e-05	0.00102	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—CXCL8—Barrett's esophagus	8.9e-05	0.001	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—CDKN2A—Barrett's esophagus	8.66e-05	0.000973	CbGpPWpGaD
Sulindac—PPARD—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	8.58e-05	0.000964	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—HGF—Barrett's esophagus	8.54e-05	0.000959	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—RELA—Barrett's esophagus	8.33e-05	0.000937	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	8.22e-05	0.000923	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	7.97e-05	0.000895	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—RELA—Barrett's esophagus	7.95e-05	0.000893	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—CXCL8—Barrett's esophagus	7.85e-05	0.000883	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—RELA—Barrett's esophagus	7.82e-05	0.000878	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	7.52e-05	0.000845	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—APC—Barrett's esophagus	7.49e-05	0.000841	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PTGES—Barrett's esophagus	7.45e-05	0.000837	CbGpPWpGaD
Sulindac—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—Barrett's esophagus	7.38e-05	0.000829	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—TP53—Barrett's esophagus	7.03e-05	0.00079	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—TP53—Barrett's esophagus	6.92e-05	0.000778	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—SST—Barrett's esophagus	6.88e-05	0.000773	CbGpPWpGaD
Sulindac—MAPK3—Disease—SLC9A1—Barrett's esophagus	6.49e-05	0.000729	CbGpPWpGaD
Sulindac—MAPK3—Cellular Senescence—TP53—Barrett's esophagus	6.38e-05	0.000717	CbGpPWpGaD
Sulindac—PPARD—Gene Expression—PPARG—Barrett's esophagus	6.25e-05	0.000702	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	6.24e-05	0.000702	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—PPARG—Barrett's esophagus	6.24e-05	0.000701	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—GAST—Barrett's esophagus	5.93e-05	0.000666	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PTGES—Barrett's esophagus	5.91e-05	0.000665	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—RELA—Barrett's esophagus	5.85e-05	0.000657	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—CYP26A1—Barrett's esophagus	5.65e-05	0.000635	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	5.58e-05	0.000627	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—CXCL8—Barrett's esophagus	5.51e-05	0.00062	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—TP53—Barrett's esophagus	5.46e-05	0.000613	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle, Mitotic—CDKN2A—Barrett's esophagus	5.43e-05	0.00061	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PTGES—Barrett's esophagus	5.25e-05	0.00059	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—RELA—Barrett's esophagus	5.05e-05	0.000567	CbGpPWpGaD
Sulindac—PPARD—Metabolism—PPARG—Barrett's esophagus	4.86e-05	0.000546	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—CDKN2A—Barrett's esophagus	4.86e-05	0.000546	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—TP53—Barrett's esophagus	4.82e-05	0.000542	CbGpPWpGaD
Sulindac—ALB—Metabolism—PTGES—Barrett's esophagus	4.79e-05	0.000538	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CYP26A1—Barrett's esophagus	4.48e-05	0.000504	CbGpPWpGaD
Sulindac—MAPK3—Immune System—HGF—Barrett's esophagus	4.48e-05	0.000503	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—RELA—Barrett's esophagus	4.46e-05	0.000501	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	4.17e-05	0.000469	CbGpPWpGaD
Sulindac—ALB—Hemostasis—HGF—Barrett's esophagus	4.11e-05	0.000462	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—SLC9A1—Barrett's esophagus	4.07e-05	0.000457	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—SST—Barrett's esophagus	4.06e-05	0.000456	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CYP26A1—Barrett's esophagus	3.98e-05	0.000447	CbGpPWpGaD
Sulindac—PTGS2—Disease—SLC9A1—Barrett's esophagus	3.86e-05	0.000434	CbGpPWpGaD
Sulindac—PPARD—Metabolism—PTGS2—Barrett's esophagus	3.82e-05	0.000429	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	3.71e-05	0.000417	CbGpPWpGaD
Sulindac—ALB—Metabolism—CYP26A1—Barrett's esophagus	3.63e-05	0.000408	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—TP53—Barrett's esophagus	3.38e-05	0.00038	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PTGES—Barrett's esophagus	3.35e-05	0.000376	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	3.31e-05	0.000372	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	3.28e-05	0.000369	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—SLC9A1—Barrett's esophagus	3.23e-05	0.000363	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—PPARG—Barrett's esophagus	3.19e-05	0.000358	CbGpPWpGaD
Sulindac—MAPK3—Disease—APC—Barrett's esophagus	3.07e-05	0.000345	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	2.94e-05	0.00033	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—SLC9A1—Barrett's esophagus	2.87e-05	0.000322	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—TP53—Barrett's esophagus	2.86e-05	0.000322	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—TP53—Barrett's esophagus	2.7e-05	0.000304	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	2.68e-05	0.000301	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—CXCL8—Barrett's esophagus	2.68e-05	0.000301	CbGpPWpGaD
Sulindac—ALB—Metabolism—SLC9A1—Barrett's esophagus	2.61e-05	0.000294	CbGpPWpGaD
Sulindac—MAPK3—Immune System—RELA—Barrett's esophagus	2.6e-05	0.000292	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CYP26A1—Barrett's esophagus	2.54e-05	0.000285	CbGpPWpGaD
Sulindac—MAPK3—Disease—PTGS2—Barrett's esophagus	2.33e-05	0.000262	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	2.31e-05	0.00026	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—APC—Barrett's esophagus	2.15e-05	0.000241	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	2.11e-05	0.000237	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.87e-05	0.000211	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PPARG—Barrett's esophagus	1.86e-05	0.000209	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—SLC9A1—Barrett's esophagus	1.83e-05	0.000205	CbGpPWpGaD
Sulindac—PTGS2—Disease—APC—Barrett's esophagus	1.82e-05	0.000205	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—RELA—Barrett's esophagus	1.68e-05	0.000189	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CXCL8—Barrett's esophagus	1.58e-05	0.000178	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PPARG—Barrett's esophagus	1.48e-05	0.000166	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.47e-05	0.000166	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PTGS2—Barrett's esophagus	1.46e-05	0.000164	CbGpPWpGaD
Sulindac—ALB—Hemostasis—TP53—Barrett's esophagus	1.38e-05	0.000155	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PPARG—Barrett's esophagus	1.31e-05	0.000147	CbGpPWpGaD
Sulindac—ALB—Metabolism—PPARG—Barrett's esophagus	1.19e-05	0.000134	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PTGS2—Barrett's esophagus	1.03e-05	0.000116	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TP53—Barrett's esophagus	9.71e-06	0.000109	CbGpPWpGaD
Sulindac—ALB—Metabolism—PTGS2—Barrett's esophagus	9.39e-06	0.000105	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PPARG—Barrett's esophagus	8.35e-06	9.38e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PTGS2—Barrett's esophagus	6.57e-06	7.38e-05	CbGpPWpGaD
